BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14243441)

  • 1. COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS.
    WAHREN B
    Nature; 1965 Jan; 205():409-10. PubMed ID: 14243441
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TYPE OF ANTIBODY RESPONSE IN MICE IMMUNIZED WITH TRANSPLANTABLE TUMOURS.
    TEE DE; WATKINS J; WANG M; GAMMACK DB
    Nature; 1964 Oct; 204():391-3. PubMed ID: 14228887
    [No Abstract]   [Full Text] [Related]  

  • 4. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular features of the H-2 class I and Qa antigens expressed on Gross virus induced AKR leukaemias.
    Festenstein H
    J Immunogenet; 1989; 16(4-5):329-33. PubMed ID: 2700994
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
    Aoki T; Johnson PA
    J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB; Moore M
    Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic studies on Graffi-virus-infected spontaenous Gross leukemia of AKR mice.
    Micheel B; Pasternak G
    Int J Cancer; 1968 Sep; 3(5):603-13. PubMed ID: 4302083
    [No Abstract]   [Full Text] [Related]  

  • 11. FURTHER STUDIES OF THE IMMUNOLOGICAL PROPERTIES OF GROSS VIRUS-INDUCED LYMPHOMAS.
    WAHREN B
    Cancer Res; 1964 Jun; 24():906-14. PubMed ID: 14190556
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration of skin in gross leukemia. II. Kinetic, preleukemic, and irradiation studies.
    Mariani T; Maruyama Y; Good RA
    J Natl Cancer Inst; 1971 Aug; 47(2):361-6. PubMed ID: 4934424
    [No Abstract]   [Full Text] [Related]  

  • 14. A CONTRIBUTION TO THE QUESTION OF THE ANTIGENICITY OF SPONTANEOUS LYMPHOID AKR LEUKAEMIA.
    BUBENIK J; ADAMCOVA B; KOLDOVSKY P
    Folia Biol (Praha); 1964; 10():293-300. PubMed ID: 14189806
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).
    Bonmassar A; Frati L; Fioretti MC; Romani L; Giampietri A; Goldin A
    Eur J Cancer (1965); 1979 Jul; 15(7):933-9. PubMed ID: 488153
    [No Abstract]   [Full Text] [Related]  

  • 16. SOME PROPERTIES OF MOUSE HISTOCOMPATIBILITY ANTIGENS: H-2, NON-H-2, X (LEUKEMIC) AND Y (SEX LINKED).
    DAVIES DA
    Ann N Y Acad Sci; 1964 Nov; 120():230-6. PubMed ID: 14233869
    [No Abstract]   [Full Text] [Related]  

  • 17. Stabilization of antigens on surfaces of malignant cells by formalin treatment.
    Kudo T; Aoki T; Morrison JL
    J Natl Cancer Inst; 1974 May; 52(5):1553-7. PubMed ID: 4598557
    [No Abstract]   [Full Text] [Related]  

  • 18. Virion and non-virion murine leukemia membrane antigens: analysis with virus-absorbed antisera.
    Moroni C; Robert-Guroff M; Martin D
    Intervirology; 1974; 3(5-6):292-304. PubMed ID: 4443190
    [No Abstract]   [Full Text] [Related]  

  • 19. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of AKR leukemogenesis by SMX-1, a dualtropic murine leukemia virus.
    Stockert E; O'Donnell PV; Obata Y; Old LJ
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3720-4. PubMed ID: 6251478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.